X @Ansem

RT Aakash Gupta (@aakashgupta)Huberman’s right that this will be a trillion-dollar drug class. He’s also telling you exactly who will own that trillion dollars and why every alternative pathway is getting shut down.Eli Lilly posted $65.2 billion in revenue in 2025, up 45% year over year. Zepbound alone did $3.6 billion in a single quarter. Their market cap just crossed $900 billion.Retatrutide is the next molecule in that pipeline. Phase 3 data showed 28.7% body weight loss in 68 weeks, nearly 40% better th ...